Concepedia

Lars Weidolf

LW

Statistics

Publications

45

Citations

3.4K

H-Index

26

Active since

1984

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (Finland)

AstraZeneca (United States)

Virginia Tech

Lars Weidolf is an author at AstraZeneca (Sweden) specializing in pharmacology, drug metabolism, and medicine.

ORCID

Publications per year

1984–2023

45

Publications

45

COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES

Xueqing Li, Tommy B. Andersson, Marie M. Ahlström et al. · Drug Metabolism and Disposition · 2004 · 642 citations

, , +17

Use of Radiolabeled Compounds in Drug Metabolism and Pharmacokinetic Studies

Emre M. Isin, Charles S. Elmore, Göran N. Nilsson et al. · Chemical Research in Toxicology · 2012 · 296 citations

, , +16

Stereoselective Metabolism of Omeprazole by Human Cytochrome P450 Enzymes

Angela Äbelö, Tommy B. Andersson, Madeleine Antonsson et al. · Drug Metabolism and Disposition · 2000 · 276 citations

, , +17

In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs

Richard A. Thompson, Emre M. Isin, Yan Li et al. · Chemical Research in Toxicology · 2012 · 214 citations

, , +17

Comparison between electrochemistry/mass spectrometry and cytochrome P450 catalyzed oxidation reactions

Ulrik Jurva, Håkan Wikström, Lars Weidolf et al. · Rapid Communications in Mass Spectrometry · 2003 · 208 citations

, , +11

1–5 of 45